Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle‐invasive bladder cancer treated with cisplatin‐based neoadjuvant chemotherapy and radical cystectomy: a single‐centre experience
暂无分享,去创建一个
J. Cheville | S. Boorjian | I. Frank | R. Karnes | M. Soligo | M. Tollefson | L. Boeri | R. Thompson | F. Quevedo
[1] Andrew C. James,et al. Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle‐invasive Urothelial Carcinoma of the Bladder , 2018, Clinical genitourinary cancer.
[2] M. Menon,et al. Neoadjuvant chemotherapy prior to radical cystectomy for muscle‐invasive bladder cancer with variant histology , 2017, Cancer.
[3] P. Gontero*,et al. Prevention of bladder cancer incidence and recurrence: tobacco use , 2017, Current opinion in urology.
[4] M. Terris,et al. Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer , 2017, Cancer Prevention Research.
[5] Fei Li,et al. Association of smoking status with prognosis in bladder cancer: A meta-analysis , 2016, Oncotarget.
[6] M. Zeegers,et al. Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis. , 2016, The Journal of urology.
[7] S. Faraj,et al. Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes. , 2015, Urologic oncology.
[8] B. Bochner,et al. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer , 2014, World Journal of Urology.
[9] M. Babjuk,et al. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. , 2013, European urology.
[10] M. Babjuk,et al. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. , 2013, European urology.
[11] L. Kiemeney,et al. Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.
[12] Choung-Soo Kim,et al. Smoking and survival after radical cystectomy for bladder cancer. , 2012, Urology.
[13] A. Chatterjee,et al. Adenylate Kinase 3 Sensitizes Cells to Cigarette Smoke Condensate Vapor Induced Cisplatin Resistance , 2011, PloS one.
[14] Y. Ho,et al. Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[15] H. Grossman,et al. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy , 2009, Cancer.
[16] Jie Xu,et al. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. , 2007, International journal of oral and maxillofacial surgery.
[17] C. Vale. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .
[18] M. Parmar,et al. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. , 2005, European urology.
[19] Nicholas J Vogelzang,et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.
[20] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[21] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[22] J. Cooper. Ajcc Cancer Staging Manual , 1997 .
[23] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.